Clinical and anamnestic predictors of poor long-term prognosis in patients with chronic heart failure and implanted cardioverter-defibrillator

Aim. Identification of a complex of clinical and anamnestic predictors of an unfavorable long-term prognosis in patients with heart failure with low left ventricular ejection fraction and an implanted cardioverter-defibrillator (ICD). Materials and methods. In 260 patients with heart failure with...

Full description

Bibliographic Details
Published in:	Терапевтический архив
Main Authors:	Nataliya B. Lebedeva, Ilias V. Talibullin, Pavel G. Parfenov, Olga L. Barbarash
Format:	Article
Language:	Russian
Published:	"Consilium Medicum" Publishing house 2025-01-01
Subjects:	heart failure implantable cardioverter defibrillators sudden cardiac death low left ventricular ejection fraction prognosis
Online Access:	https://ter-arkhiv.ru/0040-3660/article/viewFile/181611/175146

Similar Items

IMPLANTABLE CARDIOVERTER DEFIBRILLATORS ARE THE MAIN MODE FOR SUDDEN CARDIAC DEATH PREVENTION
by: L. A. Bokeria, et al.
Published: (2019-02-01)

IMPLANTABLE CARDIOVERTER DEFIBRILLATORS ARE THE MAIN MODE FOR SUDDEN CARDIAC DEATH PREVENTION
by: L. A. Bokeria, et al.
Published: (2019-02-01)

Implantable cardioverter-defibrillators in sudden cardiac death prevention: guidelines and clinical practice (literature review)
by: I. V. Talibullin, et al.
Published: (2022-04-01)

Analysis of electrotherapy of cardioverter defibrillators implanted for the primary prevention of sudden cardiac death
by: V. K. Lebedeva, et al.
Published: (2019-08-01)

Subcutaneous cardioverter-defibrillator, patient selection, implantation, postoperative management in the Krasnoyarsk
by: A. V. Prokopenko, et al.
Published: (2022-09-01)

Subcutaneous Implantable Cardioverter Defibrillator: A Contemporary Overview
by: Fabrizio Guarracini, et al.
Published: (2023-07-01)

Prognostic value of cardiovascular magnetic resonance left ventricular volumetry and geometry in patients receiving an implantable cardioverter defibrillator
by: Camila M. Urzua Fresno, et al.
Published: (2021-06-01)

A survey study of the use of a subcutaneous implantable cardioverter-defibrillator in various clinical scenarios by expert electrophysiologists in Poland
by: Maciej Kempa, et al.
Published: (2023-04-01)

Implantable cardioverter defibrillators for primary prevention in cardiomyopathies
by: Vineetha Kanneganti, et al.
Published: (2024-03-01)

Sudden Death Due to Thrombosis Associated with Implantable Cardioverter-Defibrillator Electrodes
by: Jose Maria Frutos Perez, et al.
Published: (2021-03-01)

Real world utilization and impact of the wearable cardioverter-defibrillator in a community setting
by: Aditi Naniwadekar, et al.
Published: (2017-05-01)

Use of the wearable cardioverter-defibrillator – the Swiss experience
by: Boldizsar Kovacs, et al.
Published: (2020-09-01)

Reassessment of practical usage and accumulation of real‐world data of wearable cardioverter defibrillator (WCD) in Japan—Design paper for J‐WCDR study
by: Shinichi Niwano, et al.
Published: (2021-02-01)

Subcutaneous implantable cardioverter defibrillator: Where do we stand?
by: Arindam Pande, et al.
Published: (2016-01-01)

Implantation of Implantable Cardioverter Defibrillators in Kazakhstan
by: Temirkhan Begisbayev, et al.
Published: (2022-05-01)

Safety and Tolerability of Implanted Subcutaneous Cardioverter-Defibrillator Systems
by: A. V. Vereshchagina, et al.
Published: (2022-09-01)

Use of the Wearable Cardioverter‐Defibrillator Among Patients With Myocarditis and Reduced Ejection Fraction or Ventricular Tachyarrhythmia: Data From a Multicenter Registry
by: Ibrahim El‐Battrawy, et al.
Published: (2023-09-01)

Intraoperative Defibrillation Testing of Subcutaneous Implantable Cardioverter‐Defibrillator Systems—A Simple Issue?
by: Gerrit Frommeyer, et al.
Published: (2016-03-01)

Usage of the wearable cardioverter-defibrillator during pregnancy
by: J.-Jacqueline Olic, et al.
Published: (2022-08-01)

Outcomes during and after the use of the wearable cardioverter-defibrillator in a tertiary-care and a regional hospital in Switzerland
by: Boldizsar Kovacs, et al.
Published: (2019-11-01)

Navigating the Uncommon: Case Report of Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) Successfully Managed with Implantable Cardioverter Defibrillator (ICD)
by: Sidhi Laksono Purwowiyoto, et al.
Published: (2024-10-01)

URGENT CATHETER ABLATION OF THE ELECTRICAL STORM IN PATIENTS WITH IMPLANTED CARDIOVERTER-DEFIBRILLATOR
by: R. B. Tatarsky, et al.
Published: (2015-11-01)

Current status of wearable cardioverter‐defibrillator use in Japan
by: Reina Tonegawa‐Kuji, et al.
Published: (2024-08-01)

Factors associated with the risk of progression and decompensation of heart failure in patients with an implantable cardioverter-defibrillator
by: N. B. Lebedeva, et al.
Published: (2024-04-01)

Wearable cardioverter defibrillator after cardiac surgery: Analysis of real‐life data from patients at transient risk of sudden cardiac death
by: Mohamed Elbayomi, et al.
Published: (2023-03-01)

Comparison of Preoperative ECG Screening and Device-Based Vector Analysis in Patients Receiving a Subcutaneous Implantable Cardioverter-Defibrillator
by: Szymon Budrejko, et al.
Published: (2023-12-01)

Cardioverter-defibrillator reduces mortality risk in eligible ischemic and non-ischemic cardiomyopathy patients: Sub-analysis of the multi-center Improve SCA study
by: Balbir Singh, et al.
Published: (2023-03-01)

Subcutaneous Implantable Cardioverter-defibrillator in Preventing Ventricular Arrhythmia and Sudden Cardiac Death – A Single-center Experience
by: Amarapalli Jayachandra, et al.
Published: (2024-08-01)

Outcomes in Brugada Syndrome Patients With Implantable Cardioverter-Defibrillators: Insights From the SGLT2 Registry
by: Sharen Lee, et al.
Published: (2020-03-01)

Incidence and predictors of early and late sudden cardiac death in hospitalized Japanese patients with new‐onset systolic heart failure
by: Yoshiaki Minami, et al.
Published: (2021-10-01)

Epicardial cardioverter defibrillator implantation due to post-fontan ventricular tachycardia
by: Nikolaos A Papakonstantinou, et al.
Published: (2020-01-01)

Air entrapment causing ventricular oversensing early after implantation of an extravascular implantable cardioverter-defibrillator
by: Julia Hermes, MD, et al.
Published: (2024-09-01)

PREVENTION OF SUDDEN CARDIAC DEATH BY IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS: ANALYSIS OF LARGE-SCALE CLINICAL TRIALS AND RECOMMENDATIONS OF EUROPEAN SOCIETY OF CARDIOLOGY (2015)
by: N. V. Melnik
Published: (2018-01-01)

A case report of a combined implantation technique of a cardioverter-defibrillator in an infant with long QT syndrome type 8 (Timothy's syndrome)
by: Sergei Viktorovich Nemtsov, et al.
Published: (2024-11-01)

Catheter Ablation vs. Standard Implantable Cardioverter Defibrillator Therapy in Symptomatic Brugada Syndrome: A Systematic Review and Meta-Analysis of Controlled Studies
by: Paschalis Karakasis, et al.
Published: (2025-08-01)

Evaluation of a Standardized Training and Adherence Surveillance Programme to Overcome Quality-of-Life Impairments and Enhance Compliance in Patients Treated with Wearable Cardioverter Defibrillator
by: Kellnar A, et al.
Published: (2023-02-01)

Long-term low-voltage impedance measurements in subcutaneous implantable cardioverter-defibrillators
by: Giacomo Mugnai, MD, PhD, et al.
Published: (2025-09-01)

Primary prevention implantable cardioverter defibrillator in cardiac resynchronization therapy recipients with advanced chronic kidney disease
by: Ido Goldenberg, et al.
Published: (2023-08-01)

Utilization and Outcomes of Primary Prevention Implantable Cardioverter‐Defibrillators in Patients With Hypertrophic Cardiomyopathy
by: Sarah A. Goldstein, et al.
Published: (2023-08-01)

Implantable cardioverter defibrillator therapy for secondary prevention in spontaneous coronary artery dissection: to place or not to place? This is the matter
by: Riccardo Scagliola, et al.
Published: (2020-03-01)